NO942032L - Methods for Preparation of Purified Soluble Type B and A Human Platelet-Derived Growth Factor Travel Fragments - Google Patents
Methods for Preparation of Purified Soluble Type B and A Human Platelet-Derived Growth Factor Travel FragmentsInfo
- Publication number
- NO942032L NO942032L NO942032A NO942032A NO942032L NO 942032 L NO942032 L NO 942032L NO 942032 A NO942032 A NO 942032A NO 942032 A NO942032 A NO 942032A NO 942032 L NO942032 L NO 942032L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- fragments
- growth factor
- derived growth
- travel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Cellelinjer og fremgangsmåter for meget effektiv produksjon av oppløselige peptider som har blodplate-avledede vekstfaktor-(PDGF)-ligandbindende aktivitet. Det tilveie- bringes cellelinjer som utsondrer oppløselige fragmenter fra ekstracellulære regioner av PDGF-reseptor-(PDGF-R)- polypeptider. Fremgangsmåter for anvendelse av disse celle- linjer for produksjon av fragmentene er også beskrevet.Cell lines and methods for highly efficient production of soluble peptides having platelet-derived growth factor (PDGF) ligand binding activity. Cell lines are provided which secrete soluble fragments from extracellular regions of PDGF receptor (PDGF-R) polypeptides. Methods for using these cell lines to produce the fragments are also described.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80179491A | 1991-12-02 | 1991-12-02 | |
PCT/US1992/010430 WO1993011223A1 (en) | 1991-12-02 | 1992-12-01 | Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments |
Publications (2)
Publication Number | Publication Date |
---|---|
NO942032L true NO942032L (en) | 1994-06-01 |
NO942032D0 NO942032D0 (en) | 1994-06-01 |
Family
ID=25182041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942032A NO942032D0 (en) | 1991-12-02 | 1994-06-01 | Methods for Preparation of Purified Soluble Type B and A Human Platelet-Derived Growth Factor Travel Fragments |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0619836A4 (en) |
JP (1) | JPH07501702A (en) |
AU (1) | AU675924B2 (en) |
CA (1) | CA2124957A1 (en) |
NO (1) | NO942032D0 (en) |
NZ (1) | NZ246256A (en) |
PL (1) | PL171788B1 (en) |
RU (1) | RU94046397A (en) |
WO (1) | WO1993011223A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6228600B1 (en) | 1992-07-20 | 2001-05-08 | The United States Of America As Represented By The Department Of Health And Human Services | Immunoassays for the alpha platelet-derived growth factor receptor |
US7252929B2 (en) | 1989-02-09 | 2007-08-07 | United States Of America, As Represented By The Secretary, Dept Of Health & Human Services | Methods for identifying alpha PDGFR agonists and antagonists |
US5468468A (en) * | 1989-02-09 | 1995-11-21 | The United States Of America, As Represented By The Secretary Of The Department Of Health & Human Services | Method for making a monoclonal antibody, monoclonal antibodies to α PD |
AU1411092A (en) * | 1991-01-31 | 1992-09-07 | Cor Therapeutics, Inc. | Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
US5817310A (en) | 1991-12-02 | 1998-10-06 | Cor Therapeutics, Inc. | Inhibitory immunoglobulin polypeptides to human PDGF beta receptor |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0325224B1 (en) * | 1988-01-22 | 1996-07-31 | ZymoGenetics, Inc. | Methods of producing secreted receptor analogs |
CA1339356C (en) * | 1988-02-02 | 1997-08-26 | Lewis T. Williams | Human platelet-derived growth factor receptor |
AU2899489A (en) * | 1988-02-05 | 1989-08-10 | Guardian Technologies, Inc. | Apparatus for delivering a breath sample to a solid state sensor |
AU1411092A (en) * | 1991-01-31 | 1992-09-07 | Cor Therapeutics, Inc. | Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
IE920318A1 (en) * | 1991-01-31 | 1992-07-29 | Univ California | Human platelet-derived growth factor receptors |
-
1992
- 1992-12-01 JP JP5510347A patent/JPH07501702A/en active Pending
- 1992-12-01 AU AU32364/93A patent/AU675924B2/en not_active Ceased
- 1992-12-01 WO PCT/US1992/010430 patent/WO1993011223A1/en not_active Application Discontinuation
- 1992-12-01 CA CA 2124957 patent/CA2124957A1/en not_active Abandoned
- 1992-12-01 PL PL92303989A patent/PL171788B1/en not_active IP Right Cessation
- 1992-12-01 NZ NZ24625692A patent/NZ246256A/en not_active IP Right Cessation
- 1992-12-01 EP EP93900825A patent/EP0619836A4/en not_active Withdrawn
- 1992-12-01 RU RU94046397/13A patent/RU94046397A/en unknown
-
1994
- 1994-06-01 NO NO942032A patent/NO942032D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ246256A (en) | 1996-01-26 |
CA2124957A1 (en) | 1993-06-10 |
PL171788B1 (en) | 1997-06-30 |
AU3236493A (en) | 1993-06-28 |
AU675924B2 (en) | 1997-02-27 |
EP0619836A1 (en) | 1994-10-19 |
EP0619836A4 (en) | 1996-12-04 |
RU94046397A (en) | 1996-10-10 |
WO1993011223A1 (en) | 1993-06-10 |
JPH07501702A (en) | 1995-02-23 |
NO942032D0 (en) | 1994-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1149905T3 (en) | Methods and Preparation for Polypeptide Technology | |
ATE364695T1 (en) | SHORTENED SOLUBLE TYPE I RECEPTORS FOR TUMOR NECROSIS FACTOR | |
NO891388D0 (en) | PROCEDURE FOR THE PREPARATION OF OLEFINES FROM NATURAL GAS. | |
HUP9802212A2 (en) | Recombinant anti-cd4 antibodies for human therapy | |
NO852567L (en) | THYMOPENTIN ANALOGS AND PROCEDURES FOR THEIR PREPARATION. | |
DE69426033T2 (en) | DNA ENCODING THE ALPHA-1E UNIT OF THE HUMAN CALCIUM CHANNEL | |
ES8506748A1 (en) | Teichomycin A2 pure single factors 1, 2, 3, 4 and 5 and method for their production | |
EP0151246A3 (en) | Polypeptide inhibitor of the activity of alpha-amylase, process for its preparation, its use, and pharmaceutical preparations | |
IL112557A0 (en) | Peptides that are vip antagonists and pharmaceutical compositions comprising them | |
NO942032L (en) | Methods for Preparation of Purified Soluble Type B and A Human Platelet-Derived Growth Factor Travel Fragments | |
DE69324601T2 (en) | MULTIFUNCTIONAL NEUROTROPHIC FACTORS | |
ES8203343A1 (en) | Amino substituted tetrahydrobenzindoles, a process for preparing and a pharmaceutical composition containing the same. | |
NO991867D0 (en) | Biaromatic compounds bonded via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing them | |
IT1178339B (en) | ANTI-IDIOTYPES ANTIBODIES INDUCED BY SYNTHETIC POLYPEPTIDES, DIAGNOSTIC SYSTEMS AND VACCINES BASED ON THEM AND PROCEDURE FOR THEIR PREPARATION | |
EP0104546A3 (en) | Therapeutic dipeptides | |
AU1791497A (en) | At1 receptor antagonist for the stimulation of apoptosis | |
HUP9801438A3 (en) | Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses | |
ES8504776A1 (en) | Substituted phenylpiperazine compounds suitable as antihypertensive agents, and processes for their production. | |
DK165184D0 (en) | PYRAZOLOPYRIDINE DERIVATIVES, THERAPEUTIC PREPARATIONS CONTAINING THEM AND PROCEDURES FOR PREPARING THEREOF | |
ATE69240T1 (en) | MITOGENIC PEPTIDES. | |
EP0385166A3 (en) | Theater system | |
ATE174927T1 (en) | HAEMOREGULATORY PENTA-OR HEXAPEPTIDES | |
FR2540116B1 (en) | NOVEL ANTIBIOTIC AND ANTITUMOR, LUZOPEPTIN E2, PROCESS FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS USING THE SAME | |
MX9704796A (en) | Novel peptides, their production and use. | |
MX9804706A (en) | Fused isoindolones as inhibitors of protein kinase c. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |